• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

D,L-六甲基丙烯胺肟的放射化学纯度及尿中排出的六甲基丙烯胺肟分解产物的分析

Radiochemical purity of D,L-hexamethylpropylene amine oxime and analysis of urine-excreted HMPAO decomposition species.

作者信息

Ivancević V, Kuster Z, Mastrović Z, Ivancević D

机构信息

Department of Nuclear Medicine, University Hospital Rebro, Zagreb, Yugoslavia.

出版信息

Eur J Nucl Med. 1990;17(1-2):34-7. doi: 10.1007/BF00819401.

DOI:10.1007/BF00819401
PMID:2083541
Abstract

The radiochemical purity of hexamethylproxypropylene amine oxime (HMPAO) was determined in 16 preparations using the three-strip method. Immediately post-formulation, 90.3% +/- 4.0% (mean +/- SD) of the activity was associated with the primary lipophilic complex having an Rf of 0.45 +/- 0.11. We recorded a significantly higher content of sodium pertechnetate Tc 99m in methylethyl ketone (MEK) (21.1% +/- 8.5%) than in saline (5.0% +/- 3.7%; P less than 0.001). To clarify this finding, we ran sequential chromatograms (t = 0, 1, 2, 3 h) and found that the primary complex steadily disappeared, with a rate constant of 0.31 h-1. These results suggest that there is a decomposition of the primary complex during chromatography in MEK that might be responsible for the larger fraction of sodium pertechnetate Tc 99m in MEK. Eluate composition might influence the Rf of the lipophilic complex and the rate of its in vitro decomposition. In another experimental setting, we investigated 99mTc-HMPAO decomposition species in urine after application of a suspension of labelled leukocytes by performing sequential chromatographic analyses in 11 patients. At 1 h after application, urinary activity reflected the presence of a secondary complex (84.8% +/- 9.2%) and sodium pertechnetate Tc 99m (15.2% +/- 9.2%). The values after 3 h were markedly different (91.4% +/- 4.8% and 8.6% +/- 4.8%; P less than 0.001). Thus, urinary activity mostly consisted of a secondary complex, increasing with time.

摘要

采用三条带法对16份制剂中的六甲基丙烯胺肟(HMPAO)放射化学纯度进行了测定。制剂刚制备完成后,90.3%±4.0%(均值±标准差)的活性与Rf为0.45±0.11的主要亲脂性复合物相关。我们记录到,甲基乙基酮(MEK)中高锝酸钠Tc 99m的含量(21.1%±8.5%)显著高于生理盐水中的含量(5.0%±3.7%;P<0.001)。为阐明这一发现,我们连续进行了色谱分析(时间点为0、1、2、3小时),发现主要复合物逐渐消失,消失速率常数为0.31 h⁻¹。这些结果表明,在MEK中进行色谱分析期间,主要复合物发生了分解,这可能是MEK中高锝酸钠Tc 99m比例较高的原因。洗脱液成分可能会影响亲脂性复合物的Rf及其体外分解速率。在另一个实验环境中,我们通过对11名患者进行连续色谱分析,研究了注射标记白细胞悬液后尿液中99mTc-HMPAO的分解产物。注射后1小时,尿液活性反映出存在一种次要复合物(84.8%±9.2%)和高锝酸钠Tc 99m(15.2%±9.2%)。3小时后的数值有显著差异(91.4%±4.8%和8.6%±4.8%;P<0.001)。因此,尿液活性主要由一种次要复合物组成,并随时间增加。

相似文献

1
Radiochemical purity of D,L-hexamethylpropylene amine oxime and analysis of urine-excreted HMPAO decomposition species.D,L-六甲基丙烯胺肟的放射化学纯度及尿中排出的六甲基丙烯胺肟分解产物的分析
Eur J Nucl Med. 1990;17(1-2):34-7. doi: 10.1007/BF00819401.
2
Effect of source and age of sodium pertechnetate Tc 99m on radiochemical purity of technetium Tc 99m exametazime.
Am J Hosp Pharm. 1993 Jan;50(1):103-6.
3
A comparison of three methods to determine the radiochemical purity of 99Tcm-hexamethylpropylene amine oxime (99Tcm-HMPAO).
Nucl Med Commun. 1989 Oct;10(10):733-40. doi: 10.1097/00006231-198910000-00005.
4
Effect of pertechnetate source and age on the radiochemical purity of technetium Tc 99m exametazime.高锝酸盐源及年龄对锝 Tc 99m 依沙美肟放射化学纯度的影响
Am J Hosp Pharm. 1990 Nov;47(11):2511-3.
5
A comparative study of 99Tcm-d,l-HMPAO and 99Tcm-d,l-CBPAO as leukocyte-labelling agents.锝-99m d,l-六甲基丙二胺肟和锝-99m d,l-环丙胺肟作为白细胞标记剂的比较研究。
Nucl Med Commun. 1996 Jan;17(1):76-9. doi: 10.1097/00006231-199601000-00013.
6
Radiochemical purity testing for 99Tcm-exametazime: a comparison study for three-paper chromatography.
Nucl Med Commun. 1994 Jul;15(7):569-74. doi: 10.1097/00006231-199407000-00014.
7
Miniaturized Radiochemical Purity Testing for Tc-HMPAO, Tc-HMDP, and Tc-Tetrofosmin.锝-六甲基丙二胺肟、锝-亚甲基二膦酸盐和锝-替曲膦的小型化放射化学纯度检测
J Nucl Med Technol. 2017 Sep;45(3):236-240. doi: 10.2967/jnmt.115.154484. Epub 2017 Jul 13.
8
New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.用于制备锝 Tc99m 依沙美肟的活性物质 d,l-HMPAO 的新合成路线。
Nucl Med Rev Cent East Eur. 2017;20(2):88-94. doi: 10.5603/NMR.2017.0014.
9
Evaluation of technetium 99m cyclobutylpropylene amine oxime as a potential brain perfusion imaging agent for SPET.锝99m环丁基丙二胺肟作为单光子发射计算机断层显像潜在脑灌注显像剂的评估
Eur J Nucl Med. 1990;17(5):242-7. doi: 10.1007/BF00812364.
10
Evaluation of the stability of (99m)Tc-ECD and stabilized (99m)Tc-HMPAO stored in syringes.储存在注射器中的(99m)Tc-ECD和稳定化(99m)Tc-HMPAO的稳定性评估。
J Nucl Med Technol. 2001 Dec;29(4):197-200.

本文引用的文献

1
Development of a 99Tcm-labelled radiopharmaceutical for cerebral blood flow imaging.
Nucl Med Commun. 1985 Sep;6(9):499-506. doi: 10.1097/00006231-198509000-00002.
2
A 99Tcm-labelled radiotracer for the investigation of cerebral vascular disease.
Nucl Med Commun. 1985 Aug;6(8):437-41. doi: 10.1097/00006231-198508000-00002.
3
The in vivo distribution of 99Tcm-HM-PAO in normal man.
Nucl Med Commun. 1986 Sep;7(9):647-58.
4
Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies.锝-99m六甲基丙烯胺肟立体异构体作为脑局部血流显像潜在剂的人体志愿者研究。
J Nucl Med. 1986 Feb;27(2):171-7.
5
Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion.锝-99m d,l-HM-PAO:一种用于局部脑血流灌注单光子发射计算机断层显像(SPECT)成像的新型放射性药物。
J Nucl Med. 1987 Feb;28(2):191-202.
6
Kinetic analysis of technetium-99m d,1-HM-PAO decomposition in aqueous media.锝-99m d,1-HM-PAO在水性介质中分解的动力学分析。
J Nucl Med. 1988 Sep;29(9):1568-76.
7
Inflammation: imaging with Tc-99m HMPAO-labeled leukocytes.炎症:用锝-99m 六甲基丙烯胺肟标记白细胞成像。
Radiology. 1988 Mar;166(3):767-72. doi: 10.1148/radiology.166.3.3340775.
8
Technetium-99m HM-PAO stereoisomers: differences in interaction with glutathione.锝-99m六甲基丙烯胺肟立体异构体:与谷胱甘肽相互作用的差异。
J Nucl Med. 1988 Dec;29(12):1998-2000.
9
99mTc-HM-PAO for leukocyte labeling--experimental comparison with 111In oxine in dogs.用于白细胞标记的99mTc-HM-PAO——与犬体内111In奥克辛的实验比较
Eur J Nucl Med. 1987;13(7):353-7. doi: 10.1007/BF00252994.
10
Cerebral perfusion imaging.
J Nucl Med. 1987 Aug;28(8):1364-5.